Skip to main content
Top
Published in: Journal of Ovarian Research 1/2015

Open Access 01-12-2015 | Review

The Bologna criteria for poor ovarian response: a contemporary critical appraisal

Authors: Johnny S. Younis, Moshe Ben-Ami, Izhar Ben-Shlomo

Published in: Journal of Ovarian Research | Issue 1/2015

Login to get access

Abstract

Postponement of child bearing and maternal age at first pregnancy are on the rise, contributing considerably to an increase in age-related infertility and the demand for assisted reproductive technologies (ART) treatment. This brings to the infertility clinics many women with low ovarian reserve and poor ovarian response (POR) to conventional stimulation. The Bologna criteria were released to standardize the definition of POR and pave the way for the formulation of evidence-based, efficient modalities of treatment for women undergoing IVF-ET. More than four years have passed since the introduction of these criteria and the debate is still ongoing whether a revision is due. Women with POR comprise several sub-groups with diverse baseline distinctiveness, a major issue that has fueled the discussion. Although antral follicle count (AFC) and anti-Müllerian hormone (AMH), are considered good predictors of ovarian reserve, their threshold values are still not universally standardized. Different definitions for sonographic AFC and diverse assays for AMH are held responsible for this delay in standardization. Adding established risk factors to the criteria will lead to more reliable and reproducible definition of a POR, especially in young women. The original criteria did not address the issue of oocyte quality, and the addition of risk factors may yield specific associations with quality vs. quantity. Patient’s age is the best available criterion, although limited, to predict live-birth and presumably oocyte quality. High scale studies to validate these criteria are still missing while recent evidence raises concern regarding over diagnosis.
Literature
1.
go back to reference Matthews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS Data Brief. 2009;21:1–8.PubMed Matthews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS Data Brief. 2009;21:1–8.PubMed
2.
go back to reference Leridon H, Slama R. The impact of a decline in fecundity and of pregnancy postponement on final number of children and demand for assisted reproduction technology. Hum Reprod. 2008;23:1312–9.CrossRefPubMed Leridon H, Slama R. The impact of a decline in fecundity and of pregnancy postponement on final number of children and demand for assisted reproduction technology. Hum Reprod. 2008;23:1312–9.CrossRefPubMed
3.
go back to reference Cabry R, Merviel P, Hazout A, Belloc S, Dalleac A, Copin H, et al. Management of infertility in women over 40. Maturitas. 2014;78:17–21.CrossRefPubMed Cabry R, Merviel P, Hazout A, Belloc S, Dalleac A, Copin H, et al. Management of infertility in women over 40. Maturitas. 2014;78:17–21.CrossRefPubMed
4.
go back to reference Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–24.CrossRefPubMed Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–24.CrossRefPubMed
5.
go back to reference Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril. 2011;96(1058–1061):e7.PubMed Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril. 2011;96(1058–1061):e7.PubMed
7.
go back to reference Younis JS. The Bologna criteria for poor ovarian response; has the job been accomplished? Hum Reprod. 2012;27:1874–5.CrossRefPubMed Younis JS. The Bologna criteria for poor ovarian response; has the job been accomplished? Hum Reprod. 2012;27:1874–5.CrossRefPubMed
8.
go back to reference Papathanasiou A. Implementing the ESHRE ‘poor responder’ criteria in research studies: methodological implications. Hum Reprod. 2014;29:1835–8.CrossRefPubMed Papathanasiou A. Implementing the ESHRE ‘poor responder’ criteria in research studies: methodological implications. Hum Reprod. 2014;29:1835–8.CrossRefPubMed
9.
go back to reference Venetis CA. The Bologna criteria for poor ovarian response: the good, the bad and the way forward. Hum Reprod. 2014;29:1839–41.CrossRefPubMed Venetis CA. The Bologna criteria for poor ovarian response: the good, the bad and the way forward. Hum Reprod. 2014;29:1839–41.CrossRefPubMed
10.
go back to reference Ferraretti AP, Gianaroli L. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? Hum Reprod. 2014;29:1842–5.CrossRefPubMed Ferraretti AP, Gianaroli L. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? Hum Reprod. 2014;29:1842–5.CrossRefPubMed
11.
go back to reference te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141–54.CrossRef te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141–54.CrossRef
12.
go back to reference Rotterdam ESHRE/ASRM (2004) Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertility Sterility, 81, 19-25. Rotterdam ESHRE/ASRM (2004) Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertility Sterility, 81, 19-25.
13.
go back to reference Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–45.CrossRefPubMed Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–45.CrossRefPubMed
14.
go back to reference Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab. 2006;91:786–9.CrossRefPubMed Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab. 2006;91:786–9.CrossRefPubMed
15.
go back to reference Thessaloniki ESHRE/ASRM (2008) Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertility Sterilility, 89, 505-522. Thessaloniki ESHRE/ASRM (2008) Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertility Sterilility, 89, 505-522.
16.
go back to reference Amsterdam ESHRE/ASRM (2012) Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Fertility Sterility, 97, 28-38.e25. Amsterdam ESHRE/ASRM (2012) Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Fertility Sterility, 97, 28-38.e25.
17.
go back to reference Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012;27:3481–6.CrossRefPubMed Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012;27:3481–6.CrossRefPubMed
18.
go back to reference Polyzos NP, Nwoye M, Corona R, Blockeel C, Stoop D, Haentjens P, et al. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI. Reprod Biomed Online. 2014;28:469–74.CrossRefPubMed Polyzos NP, Nwoye M, Corona R, Blockeel C, Stoop D, Haentjens P, et al. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI. Reprod Biomed Online. 2014;28:469–74.CrossRefPubMed
19.
go back to reference Busnelli A, Papaleo E, Del Prato D, La Vecchia I, Iachini E, Paffoni A, et al. A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria. Hum Reprod. 2015;30:315–22.CrossRefPubMed Busnelli A, Papaleo E, Del Prato D, La Vecchia I, Iachini E, Paffoni A, et al. A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria. Hum Reprod. 2015;30:315–22.CrossRefPubMed
20.
go back to reference Chai J, Lee VC, Yeung TW, Li HW, Ho PC, Ng EH. Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment. PLoS One. 2015;10:e0119149.CrossRefPubMedCentralPubMed Chai J, Lee VC, Yeung TW, Li HW, Ho PC, Ng EH. Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment. PLoS One. 2015;10:e0119149.CrossRefPubMedCentralPubMed
21.
go back to reference Marca L, Grisendi V, Giulini S, Sighinolfi G, Tirelli A, Argento C, et al. Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study. J Assist Reprod Genet. 2015;32:931–7.CrossRefPubMed Marca L, Grisendi V, Giulini S, Sighinolfi G, Tirelli A, Argento C, et al. Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study. J Assist Reprod Genet. 2015;32:931–7.CrossRefPubMed
22.
go back to reference Broer SL, Van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. IMPORT study group. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26–36.CrossRefPubMed Broer SL, Van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. IMPORT study group. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26–36.CrossRefPubMed
23.
go back to reference Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011;95:170–5.CrossRefPubMed Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011;95:170–5.CrossRefPubMed
24.
go back to reference Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reprod Biomed Online. 2015;31:486–96.CrossRefPubMed Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reprod Biomed Online. 2015;31:486–96.CrossRefPubMed
25.
go back to reference Wellons MF, Bates GW, Schreiner PJ, Siscovick DS, Sternfeld B, Lewis CE. Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women’s Study. Menopause. 2013;20:825–30.CrossRefPubMedCentralPubMed Wellons MF, Bates GW, Schreiner PJ, Siscovick DS, Sternfeld B, Lewis CE. Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women’s Study. Menopause. 2013;20:825–30.CrossRefPubMedCentralPubMed
26.
go back to reference Dόlleman M, Depmann M, Eijkemans MJ, Heimensem J, Broer SL, van der Stroom EM, et al. Anti-mullerian hormone is a more accurate predictor of individual time to menopause than mother’s age at menopause. Hum Reprod. 2014;29:584–91.CrossRef Dόlleman M, Depmann M, Eijkemans MJ, Heimensem J, Broer SL, van der Stroom EM, et al. Anti-mullerian hormone is a more accurate predictor of individual time to menopause than mother’s age at menopause. Hum Reprod. 2014;29:584–91.CrossRef
27.
go back to reference Qin C, Yuan Z, Yao J, Zhu W, Wu W, Xie J. AMH and AMHR2 genetic variants in Chinese women with primary ovarian insufficiency and normal age at natural menopause. Reprod Biomed Online. 2014;29:311–8.CrossRefPubMed Qin C, Yuan Z, Yao J, Zhu W, Wu W, Xie J. AMH and AMHR2 genetic variants in Chinese women with primary ovarian insufficiency and normal age at natural menopause. Reprod Biomed Online. 2014;29:311–8.CrossRefPubMed
28.
go back to reference Holte J, Brodin T, Berglund L, Hadziosmanovic N, Olovsson M, Bergh T. Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries. Fertil Steril. 2011;96:594–9.CrossRefPubMed Holte J, Brodin T, Berglund L, Hadziosmanovic N, Olovsson M, Bergh T. Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries. Fertil Steril. 2011;96:594–9.CrossRefPubMed
29.
go back to reference Fleming R, Broekmans F, Calhaz-Jorge C, Dracea L, Alexander H, Nyboe Andersen A, et al. Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation? Reprod Biomed Online. 2013;26:431–9.CrossRefPubMed Fleming R, Broekmans F, Calhaz-Jorge C, Dracea L, Alexander H, Nyboe Andersen A, et al. Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation? Reprod Biomed Online. 2013;26:431–9.CrossRefPubMed
30.
go back to reference Lan VT, Linh NK, Tuong HM, Wong PC, Howles CM. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH. Reprod Biomed Online. 2013;27:390–9.CrossRefPubMed Lan VT, Linh NK, Tuong HM, Wong PC, Howles CM. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH. Reprod Biomed Online. 2013;27:390–9.CrossRefPubMed
31.
go back to reference Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013;99:963–9.CrossRefPubMed Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013;99:963–9.CrossRefPubMed
32.
go back to reference Simonstein F, Mashiach-Eizenberg M, Revel A, Younis JS. Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization-embryo transfer. Fertil Steril. 2014;102:1301–6.CrossRefPubMed Simonstein F, Mashiach-Eizenberg M, Revel A, Younis JS. Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization-embryo transfer. Fertil Steril. 2014;102:1301–6.CrossRefPubMed
33.
go back to reference Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reprod Update. 2006;12:685–718.CrossRef Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reprod Update. 2006;12:685–718.CrossRef
34.
go back to reference Hendriks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril. 2007;87:764–75.CrossRefPubMed Hendriks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril. 2007;87:764–75.CrossRefPubMed
35.
go back to reference Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab. 2013;98:1107–14.CrossRefPubMed Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab. 2013;98:1107–14.CrossRefPubMed
36.
go back to reference Khader A, Lloyd SM, McConnachie A, Fleming R, Grisendi V, La Marca A, et al. External validation of anti-Müllerian hormone based prediction of live birth in assisted conception. J Ovarian Res. 2013;6:3.CrossRefPubMedCentralPubMed Khader A, Lloyd SM, McConnachie A, Fleming R, Grisendi V, La Marca A, et al. External validation of anti-Müllerian hormone based prediction of live birth in assisted conception. J Ovarian Res. 2013;6:3.CrossRefPubMedCentralPubMed
37.
go back to reference Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM. The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014;20:560–70.CrossRefPubMed Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM. The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014;20:560–70.CrossRefPubMed
38.
go back to reference Kedem A, Haas J, Geva LL, Yerushalmi G, Gilboa Y, Kanety H, et al. Ongoing pregnancy rates in women with low and extremely low AMH levels. A multivariate analysis of 769 cycles. PLoS One. 2013;8:e81629.CrossRefPubMedCentralPubMed Kedem A, Haas J, Geva LL, Yerushalmi G, Gilboa Y, Kanety H, et al. Ongoing pregnancy rates in women with low and extremely low AMH levels. A multivariate analysis of 769 cycles. PLoS One. 2013;8:e81629.CrossRefPubMedCentralPubMed
39.
go back to reference Haadsma ML, Groen H, Mooij TM, Burger CW, Broekmans FJ, Lambalk CB, et al. OMEGA Project Group. Miscarriage risk for IVF pregnancies in poor responders to ovarian hyperstimulation. Reprod Biomed Online. 2010;20:191–200.CrossRefPubMed Haadsma ML, Groen H, Mooij TM, Burger CW, Broekmans FJ, Lambalk CB, et al. OMEGA Project Group. Miscarriage risk for IVF pregnancies in poor responders to ovarian hyperstimulation. Reprod Biomed Online. 2010;20:191–200.CrossRefPubMed
40.
go back to reference Butts SF, Ratcliffe S, Dokras A, Seifer DB. Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates. Fertil Steril. 2013;99:382–8.CrossRefPubMedCentralPubMed Butts SF, Ratcliffe S, Dokras A, Seifer DB. Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates. Fertil Steril. 2013;99:382–8.CrossRefPubMedCentralPubMed
41.
go back to reference Devine K, Mumford SL, Wu M, DeCherney AH, Hill MJ, Propst A. Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertil Steril. 2015;104:612–9.CrossRefPubMed Devine K, Mumford SL, Wu M, DeCherney AH, Hill MJ, Propst A. Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertil Steril. 2015;104:612–9.CrossRefPubMed
42.
go back to reference Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. Reply: The Bologna criteria for poor ovarian response; has the job been accomplished? Hum Reprod. 2012;27:1875–6.CrossRef Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. Reply: The Bologna criteria for poor ovarian response; has the job been accomplished? Hum Reprod. 2012;27:1875–6.CrossRef
43.
go back to reference Younis JS. Ovarian aging: latest thoughts on assessment and management. Current Opin Obstet Gynecol. 2011;23:427–34.CrossRef Younis JS. Ovarian aging: latest thoughts on assessment and management. Current Opin Obstet Gynecol. 2011;23:427–34.CrossRef
44.
go back to reference Kaczmarek M. The timing of natural menopause in Poland and associated factors. Maturitas. 2007;57:139–53.CrossRefPubMed Kaczmarek M. The timing of natural menopause in Poland and associated factors. Maturitas. 2007;57:139–53.CrossRefPubMed
45.
go back to reference Pampiglione JS, Sharma V, Riddle AF, Mason BA, Campbell S. The effect of cycle length on the outcome of in vitro fertilization. Fertil Steril. 1988;50:603–6.PubMed Pampiglione JS, Sharma V, Riddle AF, Mason BA, Campbell S. The effect of cycle length on the outcome of in vitro fertilization. Fertil Steril. 1988;50:603–6.PubMed
46.
go back to reference Brodin T, Bergh T, Berglund L, Hadziosmanovic N, Holte J. Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization. Fertil Steril. 2008;90:1656–61.CrossRefPubMed Brodin T, Bergh T, Berglund L, Hadziosmanovic N, Holte J. Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization. Fertil Steril. 2008;90:1656–61.CrossRefPubMed
47.
go back to reference Vassena R, Vidal R, Coll O, Vernaeve V. Menstrual cycle length in reproductive age women is an indicator of oocyte quality and a candidate marker of ovarian reserve. Eur J Obstet Gynecol Reprod Biology. 2014;177:130–4.CrossRef Vassena R, Vidal R, Coll O, Vernaeve V. Menstrual cycle length in reproductive age women is an indicator of oocyte quality and a candidate marker of ovarian reserve. Eur J Obstet Gynecol Reprod Biology. 2014;177:130–4.CrossRef
48.
go back to reference Yasui T, Hayashi K, Mizunuma H, Kubota T, Aso T, Matsumura Y, et al. Factors associated with premature ovarian failure, early menopause and earlier onset of menopause in Japanese women. Maturitas. 2012;72:249–55.CrossRefPubMed Yasui T, Hayashi K, Mizunuma H, Kubota T, Aso T, Matsumura Y, et al. Factors associated with premature ovarian failure, early menopause and earlier onset of menopause in Japanese women. Maturitas. 2012;72:249–55.CrossRefPubMed
49.
go back to reference Bjelland EK, Wilkosz P, Tanbo TG, Eskild A. Is unilateral oophorectomy associated with age at menopause? A population study (the HUNT2 Survey). Hum Reprod. 2014;29:835–41.CrossRefPubMed Bjelland EK, Wilkosz P, Tanbo TG, Eskild A. Is unilateral oophorectomy associated with age at menopause? A population study (the HUNT2 Survey). Hum Reprod. 2014;29:835–41.CrossRefPubMed
50.
go back to reference Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G. Ovarian surgery for bilateral endometriomas influences age at menopause. Hum Reprod. 2011;26:3000–7.CrossRefPubMed Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G. Ovarian surgery for bilateral endometriomas influences age at menopause. Hum Reprod. 2011;26:3000–7.CrossRefPubMed
51.
go back to reference Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:3146–54.CrossRefPubMed Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:3146–54.CrossRefPubMed
52.
go back to reference Takae S, Kawamura K, Sato Y, Nishijima C, Yoshioka N, Sugishita Y, et al. Analysis of late-onset ovarian insufficiency after ovarian surgery: retrospective study with 75 patients of post-surgical ovarian insufficiency. PLoS One. 2014;9:e98174.CrossRefPubMedCentralPubMed Takae S, Kawamura K, Sato Y, Nishijima C, Yoshioka N, Sugishita Y, et al. Analysis of late-onset ovarian insufficiency after ovarian surgery: retrospective study with 75 patients of post-surgical ovarian insufficiency. PLoS One. 2014;9:e98174.CrossRefPubMedCentralPubMed
53.
go back to reference Roustan A, Perrin J, Debals-Gonthier M, Paulmyer-Lacroix O, Agostini A, Courbiere B. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome. Hum Reprod. 2015;30:840–7.CrossRefPubMed Roustan A, Perrin J, Debals-Gonthier M, Paulmyer-Lacroix O, Agostini A, Courbiere B. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome. Hum Reprod. 2015;30:840–7.CrossRefPubMed
54.
go back to reference Pelosi E, Simonsick E, Forabosca A, Garcia-Ortiz JE, Schlessinger D. Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause. Biol Reprod. 2015;92:130.CrossRefPubMed Pelosi E, Simonsick E, Forabosca A, Garcia-Ortiz JE, Schlessinger D. Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause. Biol Reprod. 2015;92:130.CrossRefPubMed
55.
go back to reference Hayatbakhsh MR, Clavarino A, Williams GM, Sina M, Najman JM. Cigarette smoking and age of menopause: a large prospective study. Maturitas. 2012;72:346–52.CrossRefPubMed Hayatbakhsh MR, Clavarino A, Williams GM, Sina M, Najman JM. Cigarette smoking and age of menopause: a large prospective study. Maturitas. 2012;72:346–52.CrossRefPubMed
56.
go back to reference Dόlleman M, Verschuren WM, Eijkermans MJ, Dollé ME, Jansen EH, Broekmans FJ, et al. Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. J Clin Endocrinol Metab. 2013;98:2106–15.CrossRef Dόlleman M, Verschuren WM, Eijkermans MJ, Dollé ME, Jansen EH, Broekmans FJ, et al. Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. J Clin Endocrinol Metab. 2013;98:2106–15.CrossRef
57.
go back to reference Freeman EW, Sammel MD, Lin H, Gracia CR . Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab. 2012;97:1673–80.CrossRefPubMedCentralPubMed Freeman EW, Sammel MD, Lin H, Gracia CR . Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab. 2012;97:1673–80.CrossRefPubMedCentralPubMed
58.
go back to reference Caserta D, Bordi G, Di Segni N, D'Ambrosio A, Mallozzi M, Moscarini M. The influence of cigarette smoking on a population of infertile men and women. Archives Genecology Obstet. 2013;287:813–8.CrossRef Caserta D, Bordi G, Di Segni N, D'Ambrosio A, Mallozzi M, Moscarini M. The influence of cigarette smoking on a population of infertile men and women. Archives Genecology Obstet. 2013;287:813–8.CrossRef
59.
go back to reference Fréour T, Masson D, Dessolle L, Allaoua D, Dejoie T, Mirallie S, et al. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen. Archives Genecology Obstet. 2012;285:1177–82.CrossRef Fréour T, Masson D, Dessolle L, Allaoua D, Dejoie T, Mirallie S, et al. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen. Archives Genecology Obstet. 2012;285:1177–82.CrossRef
60.
go back to reference Fréour T, Dessolle L, Lammers J, Barrière P. Comparison of embryo morphokinetics after in vitro fertilization-intracytoplasmic sperm injection in smoking and nonsmoking women. Fertil Steril. 2013;99:1944–50.CrossRefPubMed Fréour T, Dessolle L, Lammers J, Barrière P. Comparison of embryo morphokinetics after in vitro fertilization-intracytoplasmic sperm injection in smoking and nonsmoking women. Fertil Steril. 2013;99:1944–50.CrossRefPubMed
61.
go back to reference Cinar O, Dilbaz S, Terzioglu F, Karahalil B, Yücel C, Turk R, et al. Does cigarette smoking really have detrimental effects on outcomes of IVF? Eur J Obstet Gynecol Reprod Biol. 2014;174:106–10.CrossRefPubMed Cinar O, Dilbaz S, Terzioglu F, Karahalil B, Yücel C, Turk R, et al. Does cigarette smoking really have detrimental effects on outcomes of IVF? Eur J Obstet Gynecol Reprod Biol. 2014;174:106–10.CrossRefPubMed
62.
go back to reference Kok HS, Van Asselt KM, Van Der Schouw YT, Grobbee DE, te Velde ER, Pearson PL, et al. Subfertility reflects accelerated ovarian ageing. Hum Reprod. 2003;18:644–8.CrossRefPubMed Kok HS, Van Asselt KM, Van Der Schouw YT, Grobbee DE, te Velde ER, Pearson PL, et al. Subfertility reflects accelerated ovarian ageing. Hum Reprod. 2003;18:644–8.CrossRefPubMed
63.
go back to reference Randolph JF, Ginsburg KA, Leach RE, Blacker CM, Moghissi KS, Diamond MP, et al. Elevated early follicular gonadotropin levels in women with unexplained infertility do not provide evidence for disordered gonadotropin-releasing hormone secretion as assessed by luteinizing hormone pulse characteristics. Fertil Steril. 2003;80:320–7.CrossRefPubMed Randolph JF, Ginsburg KA, Leach RE, Blacker CM, Moghissi KS, Diamond MP, et al. Elevated early follicular gonadotropin levels in women with unexplained infertility do not provide evidence for disordered gonadotropin-releasing hormone secretion as assessed by luteinizing hormone pulse characteristics. Fertil Steril. 2003;80:320–7.CrossRefPubMed
64.
go back to reference Goverde AJ, McDonnell J, Schats R, Vermeiden JP, Homburg R, Lambalk CB. Ovarian response to standard gonadotrophin stimulation for IVF is decreased not only in older but also in younger women in couples with idiopathic and male subfertility. Hum Reprod. 2005;20:1573–7.CrossRefPubMed Goverde AJ, McDonnell J, Schats R, Vermeiden JP, Homburg R, Lambalk CB. Ovarian response to standard gonadotrophin stimulation for IVF is decreased not only in older but also in younger women in couples with idiopathic and male subfertility. Hum Reprod. 2005;20:1573–7.CrossRefPubMed
65.
go back to reference Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, et al. Impact of cancer therapies on ovarian reserve. Fertil Steril. 2012;97(134–140), e1.PubMed Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, et al. Impact of cancer therapies on ovarian reserve. Fertil Steril. 2012;97(134–140), e1.PubMed
66.
go back to reference Krawczuk-Rybak M, Leszczynska E, Poznanska M, Zelazowska-Rutkowska B, Wysocka J. The progressive reduction in the ovarian reserve in young women after anticancer treatment. Hormone Metab Res. 2013;45:813–9.CrossRef Krawczuk-Rybak M, Leszczynska E, Poznanska M, Zelazowska-Rutkowska B, Wysocka J. The progressive reduction in the ovarian reserve in young women after anticancer treatment. Hormone Metab Res. 2013;45:813–9.CrossRef
67.
go back to reference Lunsford AJ, Whelan K, McCormick K, McLaren JF. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors. Fertil Steril. 2014;101:227–31.CrossRefPubMed Lunsford AJ, Whelan K, McCormick K, McLaren JF. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors. Fertil Steril. 2014;101:227–31.CrossRefPubMed
68.
go back to reference Bentzen JG, Forman JL, Larsen EC, Pinborg A, Johannsen TH, Schmidt L, et al. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age. Hum Reprod. 2013;28:247–55.CrossRefPubMed Bentzen JG, Forman JL, Larsen EC, Pinborg A, Johannsen TH, Schmidt L, et al. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age. Hum Reprod. 2013;28:247–55.CrossRefPubMed
69.
70.
go back to reference Kuo PL, Guo HR. Mechanism of recurrent spontaneous abortions in women with mosaicism of X-chromosome aneuploidies. Fertil Steril. 2004;82:1594–601.CrossRefPubMed Kuo PL, Guo HR. Mechanism of recurrent spontaneous abortions in women with mosaicism of X-chromosome aneuploidies. Fertil Steril. 2004;82:1594–601.CrossRefPubMed
71.
go back to reference Younis JS. Ovarian aging and implications for fertility female health. Minerva Endocrinol. 2012;37:41–57.PubMed Younis JS. Ovarian aging and implications for fertility female health. Minerva Endocrinol. 2012;37:41–57.PubMed
72.
go back to reference Ferreira SI, Matoso E, Pinto M, Almeida J, Liehr T, Melo JB, et al. X-chromosome terminal deletion in a female with premature ovarian failure: Haploinsufficiency of X-linked genes as a possible explanation. Mollecular Cytogenet. 2010;3:14.CrossRef Ferreira SI, Matoso E, Pinto M, Almeida J, Liehr T, Melo JB, et al. X-chromosome terminal deletion in a female with premature ovarian failure: Haploinsufficiency of X-linked genes as a possible explanation. Mollecular Cytogenet. 2010;3:14.CrossRef
73.
go back to reference Fusco F, Paciolla M, Chen E, Li X, Genesio R, Conti A, et al. Genetic and molecular analysis of a new unbalanced X;18 rearrangement: localization of the diminished ovarian reserve disease locus in the distal Xq POF1 region. Hum Reprod. 2011;26:3186–96.CrossRefPubMed Fusco F, Paciolla M, Chen E, Li X, Genesio R, Conti A, et al. Genetic and molecular analysis of a new unbalanced X;18 rearrangement: localization of the diminished ovarian reserve disease locus in the distal Xq POF1 region. Hum Reprod. 2011;26:3186–96.CrossRefPubMed
74.
go back to reference Kim MK, Seok HH, Kim YS, Kim JS, Kim KH, Cha BJ, et al. Molecular genetic and cytogenetic characterization of a partial Xp duplication and Xq deletion in a patient with premature ovarian failure. Gene. 2014;534:54–9.CrossRefPubMed Kim MK, Seok HH, Kim YS, Kim JS, Kim KH, Cha BJ, et al. Molecular genetic and cytogenetic characterization of a partial Xp duplication and Xq deletion in a patient with premature ovarian failure. Gene. 2014;534:54–9.CrossRefPubMed
75.
go back to reference Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87:456–65.CrossRefPubMed Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87:456–65.CrossRefPubMed
77.
go back to reference Tsafrir A, Altarescu G, Margalioth E, Brooks B, Renbaum P, Levy-Lahad E, et al. PGD for fragile X syndrome: ovarian function is the main determinant of success. Hum Reprod. 2010;25:2629–36.CrossRefPubMed Tsafrir A, Altarescu G, Margalioth E, Brooks B, Renbaum P, Levy-Lahad E, et al. PGD for fragile X syndrome: ovarian function is the main determinant of success. Hum Reprod. 2010;25:2629–36.CrossRefPubMed
78.
go back to reference Karimov CB, Moragianni VA, Cronister A, Srouji S, Petrozza J, Racowsky C, et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod. 2077–2083;26. Karimov CB, Moragianni VA, Cronister A, Srouji S, Petrozza J, Racowsky C, et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod. 2077–2083;26.
79.
go back to reference Gleicher N, Weghofer A, Oktay K, Barad DH. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test? Acta Obstet Gynecol Scand. 2009;88:1024–30.CrossRefPubMed Gleicher N, Weghofer A, Oktay K, Barad DH. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test? Acta Obstet Gynecol Scand. 2009;88:1024–30.CrossRefPubMed
80.
go back to reference Ishizuka B, Okamoto N, Hamada N, Sugishita Y, Saito J, Takahashi N, et al. Number of CGG repeats in the FMR1 gene of Japanese patients with primary ovarian insufficiency. Fertil Steril. 2011;96:1170–4.CrossRefPubMed Ishizuka B, Okamoto N, Hamada N, Sugishita Y, Saito J, Takahashi N, et al. Number of CGG repeats in the FMR1 gene of Japanese patients with primary ovarian insufficiency. Fertil Steril. 2011;96:1170–4.CrossRefPubMed
81.
go back to reference Lledo B, Guerrero J, Ortiz JA, Morales R, Ten J, Llacer J, et al. Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response. Hum Reprod. 2012;27:609–14.CrossRefPubMed Lledo B, Guerrero J, Ortiz JA, Morales R, Ten J, Llacer J, et al. Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response. Hum Reprod. 2012;27:609–14.CrossRefPubMed
82.
go back to reference Voorhuis M, Onland-Moret NC, Janse F, Ploos van Amstel HK, Goverde AJ, Lambalk CB, et al. Dutch Primary Ovarian Insufficiency Consortium. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency. Hum Reprod. 2014;29:1585–93.CrossRefPubMed Voorhuis M, Onland-Moret NC, Janse F, Ploos van Amstel HK, Goverde AJ, Lambalk CB, et al. Dutch Primary Ovarian Insufficiency Consortium. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency. Hum Reprod. 2014;29:1585–93.CrossRefPubMed
83.
go back to reference Voorhuis M, Onland-Moret NC, Fauser BC, Ploos van Amstel HK, van der Schouw YT, Broekmans FJ. The association of CGG repeats in the FMR1 gene and timing of natural menopause. Hum Reprod. 2013;28:496–501.CrossRefPubMed Voorhuis M, Onland-Moret NC, Fauser BC, Ploos van Amstel HK, van der Schouw YT, Broekmans FJ. The association of CGG repeats in the FMR1 gene and timing of natural menopause. Hum Reprod. 2013;28:496–501.CrossRefPubMed
84.
go back to reference Klinkert ER, Broekmans FJ, Looman CW, Te Velde ER. A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertility Sterility. 2004;81:1247–1253. Klinkert ER, Broekmans FJ, Looman CW, Te Velde ER. A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles. Fertility Sterility. 2004;81:1247–1253.
85.
go back to reference Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705–14.CrossRefPubMed Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705–14.CrossRefPubMed
86.
go back to reference La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–30.CrossRefPubMed La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–30.CrossRefPubMed
Metadata
Title
The Bologna criteria for poor ovarian response: a contemporary critical appraisal
Authors
Johnny S. Younis
Moshe Ben-Ami
Izhar Ben-Shlomo
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Ovarian Research / Issue 1/2015
Electronic ISSN: 1757-2215
DOI
https://doi.org/10.1186/s13048-015-0204-9

Other articles of this Issue 1/2015

Journal of Ovarian Research 1/2015 Go to the issue